Pharmaceutical Product
-
{
- All
- News
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Emcure Pharmaceuticals Withdraws Proposed IPO
The pharma company intends to utilise the net proceeds for setting up of new manufacturing facilities and expansion of existing manufacturing facilities, research and development and general corporate purposes.
-
Drug Regulator Fixes Prices of 30 Formulation Packs
The National Pharmaceutical Pricing Authority (NPPA) has fixed prices of 30 formulation packs, including drugs used to treat various diseases such as tuberculosis, diabetes, asthma and antibiotics.
-
Drug Firms Directed to Pass On Lower Excise Duty Benefit
Medicines are set to become cheaper as the National Pharmaceutical Pricing Authority (NPPA) has directed drug makers to pass on benefits of lower excise duty to consumers.
-
Emcure Pharmaceuticals Withdraws Proposed IPO
The pharma company intends to utilise the net proceeds for setting up of new manufacturing facilities and expansion of existing manufacturing facilities, research and development and general corporate purposes.
-
Germany's Bayer vows to fight for anti-cancer drug patent in India
German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Emcure Pharmaceuticals Withdraws Proposed IPO
The pharma company intends to utilise the net proceeds for setting up of new manufacturing facilities and expansion of existing manufacturing facilities, research and development and general corporate purposes.
-
Drug Regulator Fixes Prices of 30 Formulation Packs
The National Pharmaceutical Pricing Authority (NPPA) has fixed prices of 30 formulation packs, including drugs used to treat various diseases such as tuberculosis, diabetes, asthma and antibiotics.
-
Drug Firms Directed to Pass On Lower Excise Duty Benefit
Medicines are set to become cheaper as the National Pharmaceutical Pricing Authority (NPPA) has directed drug makers to pass on benefits of lower excise duty to consumers.
-
Emcure Pharmaceuticals Withdraws Proposed IPO
The pharma company intends to utilise the net proceeds for setting up of new manufacturing facilities and expansion of existing manufacturing facilities, research and development and general corporate purposes.
-
Germany's Bayer vows to fight for anti-cancer drug patent in India
German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.
